STOCK TITAN

Stephen M. Kelsey (RVMD) files to sell 4,071 restricted shares; prior 4,302 sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Stephen Michael Kelsey filed a Form 144 notice to sell 4,071 shares of Common Stock of Revolution Medicines. The filing lists restricted stock unit grants dated 03/01/2023, 03/01/2024, and 03/01/2025 totaling 4,071 units. It also reports that 4,302 shares were sold on 03/17/2026 for $427,964.68.

Positive

  • None.

Negative

  • None.

Insights

Notice filed under Form 144 reports proposed resale and a recent sale by an affiliate.

The filing lists 4,071 restricted stock units scheduled for resale and records a prior sale of 4,302 shares on 03/17/2026 for $427,964.68. This is a procedural disclosure under resale rules.

Regulatory implications are routine: transactions reported on Form 144 permit brokered resale under SEC rules when conditions are met. Subsequent trading activity will appear in market or insider filings.

Registered/offered shares 4,071 shares Restricted stock unit grants dated 03/01/2023–03/01/2025
Shares sold (past 3 months) 4,302 shares Sale date 03/17/2026 for $427,964.68
Proceeds reported $427,964.68 Proceeds from 4,302-share sale on 03/17/2026
Restricted stock unit grant financial
"Restricted stock unit grant | Issuer | 1272 | 03/01/2023"
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months | Common Stock | 03/17/2026"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Stephen Michael Kelsey report on Form 144 for RVMD?

He reported a notice to sell 4,071 shares of Common Stock and disclosed prior sales of 4,302 shares on 03/17/2026 for $427,964.68. The filing lists restricted stock unit grants from 03/01/2023–03/01/2025.

How many shares were sold in the past three months according to the filing?

The filing records a sale of 4,302 shares on 03/17/2026 with gross proceeds of $427,964.68. This is listed in the "Securities Sold During The Past 3 Months" section.

What restricted awards are listed in the Form 144?

The notice lists restricted stock unit grants dated 03/01/2023 (1,272 units), 03/01/2024 (1,635 units), and 03/01/2025 (1,164 units), totaling 4,071 units.

Does the Form 144 indicate who will receive sale proceeds?

The filing does not attach a proceeds recipient statement beyond stating the seller's name. The document lists the seller as Stephen Michael Kelsey; specific proceeds allocation is not detailed in the provided excerpt.